Joining Hands for a Cause: Avidity Biosciences Raises Awareness for National Muscular Dystrophy Awareness Month Alongside Patients and Advocates
Description
Avidity supports World Duchenne Awareness Day, International Myotonic Dystrophy Awareness Day, FSHD Society Walk & Roll to Cure FSHD and Global Genes Week in RARE. Avidity reported groundbreaking data in all three clinical programs addressing rare muscular dystrophies: myotonic dystrophy type 1 (DM1), facioscapulohumeral muscular dystrophy (FSHD) and Duchenne muscular dystrophy amenable to exon 44 skipping (DMD44).
SAN DIEGO , Sept. 5, 2024 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced it is joining with patient and advocacy communities to raise awareness during National Muscular Dystrophy Awareness Month, an annual observance that takes place every September to support families who are impacted by neuromuscular diseases.
How this will affect me
As an individual, supporting events like National Muscular Dystrophy Awareness Month and being aware of rare muscular dystrophies can help increase understanding and empathy towards those affected by these conditions. It can also inspire you to get involved in advocacy efforts, fundraising, and spreading awareness to make a positive impact on the lives of patients and their families.
How this will affect the world
By joining hands with patient and advocacy communities, Avidity Biosciences is leading the way in raising awareness for rare muscular dystrophies on a global scale. This initiative not only sheds light on these often overlooked conditions but also fosters a sense of unity and support within the community. Ultimately, increased awareness can lead to improved resources, research, and treatment options for individuals affected by muscular dystrophies worldwide.
Conclusion
Joining forces for a cause as important as raising awareness for rare muscular dystrophies during National Muscular Dystrophy Awareness Month is a powerful way to make a difference in the lives of patients and their families. Avidity Biosciences’ dedication to supporting these initiatives alongside patients and advocates sets a positive example for the biopharmaceutical industry and the world at large. Together, we can create a more inclusive and compassionate society for those affected by neuromuscular diseases.
